Sunshine Biopharma earnings were -$5.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SBFM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.2M, up 80.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SBFM reported annual earnings of -$5.1M, with 13.9% growth. The next SBFM earnings date is May 19, 2025.
What were Sunshine Biopharma's earnings last quarter?
On SBFM's earnings call on Invalid Date, Sunshine Biopharma (NASDAQ: SBFM) reported Q4 2024 earnings per share (EPS) of $6.29, up 107.34% year over year. Total SBFM earnings for the quarter were -$2.16 million. In the same quarter last year, Sunshine Biopharma's earnings per share (EPS) was -$85.65.
The next SBFM earnings call is Invalid Date. Add SBFM to your watchlist to be reminded of Sunshine Biopharma's next earnings date.
What was SBFM's earnings growth in the past year?
As of Sunshine Biopharma's earnings date in Invalid Date, Sunshine Biopharma's earnings has grown year over year. SBFM earnings in the past year totalled -$5.13 million.
Is Sunshine Biopharma profitable or losing money?
As of the last Sunshine Biopharma earnings report, Sunshine Biopharma is currently losing money. Sunshine Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$5.13 million, a 13.94% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.